STUDY_ID	USUBJID	Visit Number	Visit Name	Visit Date	Treatment	Height_CM	Weight_KG
TR171	OBS336-201_01	0	Baseline	2016-03-02	75 mg QD	181	99.70
TR171	OBS336-201_02	0	Baseline	2016-02-29	Placebo	186	114.80
TR171	OBS336-201_03	0	Baseline	2016-03-11	75 mg QD	167	90.40
TR171	OBS336-201_04	0	Baseline	2016-03-09	Placebo	179	111.20
TR171	OBS336-201_05	0	Baseline	2016-02-26	Placebo	165	84.10
TR171	OBS336-201_06	0	Baseline	2016-03-01	Placebo	170	91.50
TR171	OBS336-201_07	0	Baseline	2016-03-04	75 mg QD	163	90.80
TR171	OBS336-201_08	0	Baseline	2016-03-07	75 mg QD	185	112.40
TR171	OBS336-201_01	1	Week 1	2016-03-09	75 mg QD	181	97.71
TR171	OBS336-201_02	1	Week 1	2016-03-07	Placebo	186	115.95
TR171	OBS336-201_03	1	Week 1	2016-03-18	75 mg QD	167	89.50
TR171	OBS336-201_04	1	Week 1	2016-03-16	Placebo	179	111.76
TR171	OBS336-201_05	1	Week 1	2016-03-04	Placebo	165	83.26
TR171	OBS336-201_06	1	Week 1	2016-03-08	Placebo	170	91.32
TR171	OBS336-201_07	1	Week 1	2016-03-11	75 mg QD	163	88.53
TR171	OBS336-201_08	1	Week 1	2016-03-14	75 mg QD	185	111.84
TR171	OBS336-201_01	2	Week 2	2016-03-16	75 mg QD	181	95.71
TR171	OBS336-201_02	2	Week 2	2016-03-14	Placebo	186	117.10
TR171	OBS336-201_03	2	Week 2	2016-03-25	75 mg QD	167	88.59
TR171	OBS336-201_04	2	Week 2	2016-03-23	Placebo	179	112.31
TR171	OBS336-201_05	2	Week 2	2016-03-11	Placebo	165	82.42
TR171	OBS336-201_06	2	Week 2	2016-03-15	Placebo	170	91.13
TR171	OBS336-201_07	2	Week 2	2016-03-18	75 mg QD	163	86.26
TR171	OBS336-201_08	2	Week 2	2016-03-22	75 mg QD	185	111.28
TR171	OBS336-201_01	3	Week 3	2016-03-23	75 mg QD	181	93.72
TR171	OBS336-201_02	3	Week 3	2016-03-21	Placebo	186	118.24
TR171	OBS336-201_03	3	Week 3	2016-04-01	75 mg QD	167	87.69
TR171	OBS336-201_04	3	Week 3	2016-03-30	Placebo	179	112.87
TR171	OBS336-201_05	3	Week 3	2016-03-18	Placebo	165	83.26
TR171	OBS336-201_06	3	Week 3	2016-03-22	Placebo	170	90.95
TR171	OBS336-201_07	3	Week 3	2016-03-25	75 mg QD	163	83.99
TR171	OBS336-201_08	3	Week 3	2016-03-29	75 mg QD	185	110.71
TR171	OBS336-201_01	4	Week 4	2016-03-30	75 mg QD	181	91.72
TR171	OBS336-201_02	4	Week 4	2016-03-28	Placebo	186	119.39
TR171	OBS336-201_03	4	Week 4	2016-04-08	75 mg QD	167	88.59
TR171	OBS336-201_04	4	Week 4	2016-04-06	Placebo	179	113.42
TR171	OBS336-201_05	4	Week 4	2016-03-25	Placebo	165	84.10
TR171	OBS336-201_06	4	Week 4	2016-03-29	Placebo	170	90.77
TR171	OBS336-201_07	4	Week 4	2016-04-01	75 mg QD	163	81.72
TR171	OBS336-201_08	4	Week 4	2016-04-05	75 mg QD	185	110.15
TR171	OBS336-201_01	5	Week 5	2016-04-06	75 mg QD	181	89.73
TR171	OBS336-201_02	5	Week 5	2016-04-04	Placebo	186	120.54
TR171	OBS336-201_03	5	Week 5	2016-04-15	75 mg QD	167	89.50
TR171	OBS336-201_04	5	Week 5	2016-04-12	Placebo	179	113.98
TR171	OBS336-201_05	5	Week 5	2016-04-01	Placebo	165	84.94
TR171	OBS336-201_06	5	Week 5	2016-04-05	Placebo	170	90.59
TR171	OBS336-201_07	5	Week 5	2016-04-08	75 mg QD	163	79.45
TR171	OBS336-201_08	5	Week 5	2016-04-12	75 mg QD	185	109.59
TR171	OBS336-201_01	6	Week 6	2016-04-13		181	87.74
TR171	OBS336-201_02	6	Week 6	2016-04-11		186	121.69
TR171	OBS336-201_03	6	Week 6	2016-04-14		167	90.40
TR171	OBS336-201_04	6	Week 6	2016-04-19		179	114.54
TR171	OBS336-201_05	6	Week 6	2016-04-08		165	85.78
TR171	OBS336-201_06	6	Week 6	2016-04-12		170	90.40
TR171	OBS336-201_07	6	Week 6	2016-04-15		163	77.18
TR171	OBS336-201_08	6	Week 6	2016-04-19		185	109.03
